Page last updated: 2024-09-05

nk3201 and Alveolitis, Fibrosing

nk3201 has been researched along with Alveolitis, Fibrosing in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jin, D; Kim, S; Miyazaki, M; Muramatsu, M; Okamoto, Y; Sakaguchi, M; Takai, S	1

Other Studies

1 other study(ies) available for nk3201 and Alveolitis, Fibrosing

Article	Year
A specific chymase inhibitor, NK3201, suppresses bleomycin-induced pulmonary fibrosis in hamsters. European journal of pharmacology, 2004, Jun-16, Volume: 493, Issue:1-3 Topics: Acetamides; Administration, Oral; Animals; Bleomycin; Chymases; Collagen Type III; Cricetinae; Drug Evaluation, Preclinical; Enzyme Inhibitors; Japan; Lung; Male; Pulmonary Fibrosis; Pyrimidines; RNA, Messenger; Serine Endopeptidases; Tissue Extracts	2004

Article

Year

A specific chymase inhibitor, NK3201, suppresses bleomycin-induced pulmonary fibrosis in hamsters.

European journal of pharmacology, 2004, Jun-16, Volume: 493, Issue:1-3

Topics: Acetamides; Administration, Oral; Animals; Bleomycin; Chymases; Collagen Type III; Cricetinae; Drug Evaluation, Preclinical; Enzyme Inhibitors; Japan; Lung; Male; Pulmonary Fibrosis; Pyrimidines; RNA, Messenger; Serine Endopeptidases; Tissue Extracts

2004